Role of 2-[(18)F]FDG as a Radiopharmaceutical for PET/CT in Patients with COVID-19: A Systematic Review

Some recent studies evaluated the role of fluorine-18 fluorodeoxyglucose (2-[(18)F]FDG) as a radiopharmaceutical for positron emission tomography/computed tomography (PET/CT) imaging in patients with Coronavirus Disease (COVID-19). This article aims to perform a systematic review in this setting. A...

Descripción completa

Detalles Bibliográficos
Autores principales: Annunziata, Salvatore, Delgado Bolton, Roberto C., Kamani, Christel-Hermann, Prior, John O., Albano, Domenico, Bertagna, Francesco, Treglia, Giorgio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696195/
https://www.ncbi.nlm.nih.gov/pubmed/33182811
http://dx.doi.org/10.3390/ph13110377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696195/
https://www.ncbi.nlm.nih.gov/pubmed/33182811
http://dx.doi.org/10.3390/ph13110377

Ejemplares similares